Cardiocentro Ticino Institute

What Cardiocentro Ticino Institute does

Istituto Cardiocentro Ticino is a specialized cardiac care institute founded in 1999 in Lugano, Switzerland, operating as the cantonal cardiac center within the Ente Ospedaliero Cantonale (EOC) public hospital network. The institute provides tertiary and quaternary cardiovascular services spanning interventional cardiology, electrophysiology and cardiac pacing, cardiac imaging, cardiac and thoracic surgery, and cardiovascular intensive care, with 24/7 emergency cardiac services. It operates a 9-bed intensive care unit, hybrid operating room, advanced cardiac imaging suites, and the Lugano Cell Factory GMP facility — a Good Manufacturing Practice stem cell processing unit that pioneered the first cardiovascular stem cell transplant for acute myocardial infarction in Switzerland in 2004.

The institute's technology stack centers on minimally invasive interventional techniques including MitraClip mitral valve repair, transcatheter aortic valve implantation (TAVI), radial artery access catheterization (Radial Lounge), and leadless pacemakers, complemented by 3D echocardiography, cardiac CT/MRI, and nuclear imaging. Research and clinical trial activity is anchored by a CHF 2 million+ Swiss National Science Foundation IICT grant for the TITAN-PARADISE randomized multicenter trial in approximately 2,000 patients, plus academic partnerships with USI (PhD in Human Cardiovascular Sciences) and CTU Bern.

Revenue flows from clinical cardiac care reimbursed through mandatory Swiss health insurance (LAMal) and cantonal funding, supplemented by competitive research grants, professional training programs (cardiology and cardiac surgery fellowships, nursing education), and educational events such as the biennial MTE international symposium. The institute serves cardiac patients across Ticino canton as its primary segment, with secondary segments in medical trainees and practicing cardiovascular specialists. Other go-to-market activities include community prevention programs (CardioWalkTicino walking trails, Bello Buono e Salutare nutrition platform), the CCT Magazine publication, and partnerships with Fondazione Ticino Cuore for cantonal defibrillation coverage.

Name

Cardiocentro Ticino Institute

Legal name

Istituto Cardiocentro Ticino

Website

https://cardiocentro.org

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

251–500 employees

Short description

Cardiocentro Ticino is the cantonal cardiac center for Ticino, Switzerland, operating within the EOC hospital network and delivering tertiary cardiology, cardiac surgery, thoracic surgery, and intensive care. It serves Ticino residents and trains cardiovascular specialists via fellowship and PhD programs.

Ownership category

akta.pro rank

Product category

Cardiac Healthcare Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)

akta.pro secondary industries

General Cardiology (Consultative) (HLAKABAA), Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI), Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB), Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)

Keywords

• Cardiac care services
• Interventional cardiology
• Cardiac surgery
• Electrophysiology services
• Cardiac rehabilitation

Headquarters

HQ city

Lugano

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Cardiac Care Services: Tertiary and quaternary cardiac care services including cardiology, cardiac surgery, and intensive care provided to patients through Swiss health insurance system and canton-funded healthcare
2. Research Grants and Clinical Trials: Externally funded research activities including SNF (Swiss National Science Foundation) grants for investigator-initiated clinical trials, receiving over 2 million CHF for TITAN-PARADISE study
3. Professional Medical Training: Fellowship programs, PhD training, and continuing medical education for cardiologists and cardiac surgeons
4. Educational Events and Conferences: International symposiums including MTE (Meet The Experts) organized biennially, attracting international faculty and participants

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Cardiocentro Ticino is a specialized cardiac care center providing tertiary and quaternary cardiovascular services across cardiology, cardiothoracic and vascular surgery, and anesthesia with intensive care. Its offering spans interventional cardiology, electrophysiology and cardiac pacing, cardiac imaging, cardiac surgery, minimally invasive procedures (MitraClip, TAVI, leadless pacemakers), cardiovascular stem cell therapy via the Lugano Cell Factory GMP, cardiac rehabilitation, and prevention programs, delivered 24/7 at its Lugano facility as the cantonal cardiac center for Ticino.

Product overview

Cardiocentro Ticino Institute is a specialized cardiac care center in Lugano, Switzerland, affiliated with the Ente Ospedaliero Cantonale (EOC). The institute offers a comprehensive portfolio of cardiovascular services including cardiology (interventional, electrophysiology, imaging), cardiac and thoracic surgery, and intensive care. The institute is distinguished by innovative programs such as the Hybrid Operating Room for minimally invasive procedures, MitraClip, TAVI, the Lugano Cell Factory for stem cell therapies, and the pioneering Radial Lounge technique. Additional offerings include the MTE biennial symposium, professional training programs, PhD research collaboration with USI, and public health initiatives like CardioWalkTicino and Bello Buono e Salutare. The institute publishes CCT Magazine and maintains active research with SNF funding.

Differentiator

Problem solved

Functional benefit

Brands

• Lugano Cell Factory GMP: A GMP (Good Manufacturing Practice) facility for stem cell processing and cellular therapy, among the pioneers in Switzerland for cardiovascular cell therapies.
• Bello Buono e Salutare
• CardioWalkTicino
• CCT Magazine
• Baricentro

Products and services

• Cardiology Service Comprehensive cardiology department led by Prof. Marco Valgimigli, offering interventional cardiology, electrophysiology and cardiac pacing, cardiac imaging, cardiac pacing, cardiac rehabilitation, and rare cardiovascular disease services for patients across Ticino.
• Cardiothoracic and Vascular Surgery Cardiac and thoracic surgery department providing surgical treatment of valvular disease, coronary artery disease, and thoracic conditions using minimally invasive techniques; expanded in March 2026 with arrival of Prof. Stefano Cafarotti as Chief of Thoracic Surgery.
• Anesthesia and Cardiovascular and Thoracic Intensive Medicine Anesthesia and intensive care service providing perioperative care, operating room support, cardiology support, and intensive care (level -1, 9 beds) for cardiac and complex heart patients.
• Hybrid Operating Room Advanced surgical facility combining a traditional operating room with catheterization capabilities, enabling minimally invasive procedures through collaboration between cardiologists, cardiac surgeons, and anesthesiologists.
• Lugano Cell Factory GMP Good Manufacturing Practice facility for stem cell processing and cellular therapies, pioneering cardiovascular cell therapy in Switzerland since the first transplant in August 2004.
• MitraClip System (Percutaneous Mitral Valve Repair) Minimally invasive mitral valve repair technique for treating mitral regurgitation without open-heart surgery.
• Percutaneous Aortic Valve Implantation (TAVI) Transcatheter aortic valve implantation for treating aortic valve disease through a minimally invasive catheter-based approach.
• Electrophysiology and Cardiac Pacing Service Service dedicated to prevention, diagnosis, and treatment of heart rhythm disorders including catheter ablation and pacemaker/implantable defibrillator procedures; EHRA certified in 2023.
• Cardiac Imaging Service Advanced cardiac imaging including echocardiography (including 3D transesophageal), cardiac MRI, CT, and nuclear imaging for diagnosis of cardiovascular conditions.
• Interventional Cardiology Service Catheter-based treatments for coronary artery disease including angioplasty, stenting, and specialized procedures for complex lesions and vulnerable plaques.
• Rehabilitation and Preventive Cardiology Cardiovascular rehabilitation programs helping patients recover and maintain heart health through supervised exercise, education, and lifestyle modification.
• Radial Lounge (Transradial Catheterization) Radial artery access technique for cardiac catheterization procedures, allowing interventions through the wrist artery for improved patient comfort and faster recovery.
• Rare Cardiovascular Diseases Clinic Specialized clinic for diagnosis and treatment of rare cardiovascular diseases including amyloidosis and hereditary arrhythmia syndromes.
• Amyloidosis Clinic Specialized clinic for AL and ATTR amyloidosis, part of IOSI and ICCT collaboration in Ticino for early diagnosis and treatment of this systemic disease.
• Cardio-Psychotherapy Service Psychotherapy service for cardiac patients addressing the psychological aspects of heart disease and recovery.
• Professional Training - Cardiology Postgraduate medical education programs in cardiology including EPA-based competency framework, 3D echocardiography courses, and fellowship opportunities; only Category A ISFM-recognized cardiology training center in Ticino.
• Professional Training - Cardiac and Thoracic Surgery Specialized training programs for cardiac and thoracic surgeons in advanced surgical techniques and procedures.
• PhD in Human Cardiovascular Sciences Doctoral research program investigating the link between cardiovascular procedures, emboli, and neurologic disorders, offered in collaboration with Università della Svizzera Italiana (USI).
• MTE - Meet The Experts International Symposium Biennial international interventional symposium on high-risk and innovative cardiac interventions, organized by Cardiocentro since 1998, featuring live cases, lectures, and expert discussions; 9th edition (MTE 2016) attracted 250 participants, 77 speakers from 16 countries, 34 talks, and 12 live cases.
• CardioWalkTicino Prevention Program Cardiovascular disease prevention project featuring walking trails throughout the canton, designed to promote healthy outdoor physical activity and educate participants on listening to their bodies for cardiovascular health.
• Bello Buono e Salutare Nutrition Education Nutrition and balanced lifestyle platform providing expert advice on diet and wellness to help reduce cardiovascular disease risk, using new media for dialogue with the population.
• CCT Magazine Official quarterly publication of Cardiocentro Ticino covering diagnostic and therapeutic innovations, prevention, rehabilitation, perspectives and hopes; available via mobile apps and PDF downloads since 2007.

Quantifiable outcome

• First stem cell transplant for acute MI in Switzerland (2004)
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration9 records

Feature8 records

Partnerships

14 partnerships are on record, tiered core, supporting and minor.

• Ente Ospedaliero Cantonale (EOC)coreStrategic or Co-development PartnerParent organization providing institutional governance, administrative support, and integration with the broader cantonal hospital network. Cardiocentro is part of EOC's specialized services network.
• Fondazione Ticino CuorecoreStrategic or Co-development PartnerFoundation established in 2005 jointly by FCTSA and Cardiocentro Ticino to guarantee immediate life-saving measures for citizens experiencing sudden cardiac arrest. Conducts CPR and defibrillation training and maintains a cantonal network of automated external defibrillators (AEDs).
• Servizio Trasfusionale della Svizzera Italiana (Swiss Red Cross)coreStrategic or Co-development PartnerBlood transfusion service operated by Swiss Red Cross, located in the same building as Cardiocentro, ensuring immediate blood availability for any operating room need or emergency.
• Associazione Amici del Cardiocentro TicinosupportingStrategic or Co-development PartnerPatient support association founded in June 2005 by former patients to express gratitude. Promotes Cardiocentro activities, supports cardiac pathology patients, and provides scientific communication support.
• Fondazione Bambini Cardiopatici nel MondosupportingStrategic or Co-development PartnerFoundation supporting 'flying doctors' - volunteer surgeons, anesthesiologists, and cardiologists providing free cardiac surgery for children with congenital heart disease in developing countries.
• Associazione Studenti Ticinesi di Medicina (ASTiM)supportingStrategic or Co-development PartnerNon-profit association creating privileged connections between Ticinese medical students and the canton's healthcare offerings, supporting access to Swiss medical faculties.
• Clinical Trial Unit EOC (Prof. Alessandro Ceschi)coreStrategic or Co-development PartnerPartnership for clinical trial organizational support for SNF-funded TITAN-PARADISE study, providing international network coordination and regulatory expertise.
• CTU Bern (Prof.ssa Eva Segelov)coreStrategic or Co-development PartnerClinical Trial Unit Bern partnership for TITAN-PARADISE study, ensuring compliance with international clinical trial standards and methodological rigor.
• Universita della Svizzera Italiana (USI)coreStrategic or Co-development PartnerAcademic partnership for PhD training in Human Cardiovascular Sciences, hosting defenses at USI facilities and involving USI faculty in doctoral supervision.
• CHUV Lausanne (Cellular Therapy Unit)coreStrategic or Co-development PartnerAcademic medical partnership through Prof. Lee Ann Laurent-Applegate maintaining dual leadership at CHUV while directing Lugano Cell Factory, ensuring academic relationships and research collaboration opportunities.
• European Society of CardiologysupportingStrategic or Co-development PartnerLive event collaboration for MTE symposium; EP Europace journal affiliation through Prof. Auricchio's editorship; access to ESC core curriculum for training programs.
• Swiss Society of CardiologysupportingStrategic or Co-development PartnerOfficial accreditation for MTE symposium (18 hours Category 1A credits); partnership for SGK research prize; professional society collaboration.
• EBAC (European Board for Accreditation in Cardiology)supportingStrategic or Co-development PartnerEuropean accreditation body providing 16 hours of external CME credits for MTE international symposium participants.
• Swiss Healthcare Companies (Various Donors)minorOthersVarious companies and individuals donated supplies during COVID-19 pandemic including Chocolat Stella SA, Menarini Group, Nestlé, Biosensors, Lions Club, and private donors providing PPE, refreshments, and equipment.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• German Heart Institute Berlin (DHZB): Specialty cardiac hospital in Germany focused exclusively on cardiovascular medicine, including cardiac surgery, interventional cardiology, and pediatric cardiology. Closest international comparable in scope and dedicated cardiac specialty positioning.
• Inselspital, University Hospital Bern: Swiss university hospital with a comprehensive cardiology and cardiac surgery department and active clinical research program. Direct domestic peer operating in the same Swiss specialty cardiac care space with a larger catchment and academic footprint.
• CHUV Lausanne - Cardiology: University hospital serving French-speaking Switzerland with a major cardiology and cardiac surgery program. Direct peer providing tertiary cardiac care in the same linguistic region, with academic ties to Cardiocentro Ticino via the Lugano Cell Factory leadership.
• University Hospital Zurich (USZ) Heart Center: Heart center at one of Switzerland's leading university hospitals, offering interventional cardiology, cardiac surgery, and electrophysiology. Comparable service lines and patient segments, with substantially larger scale and academic resources.
• German Heart Center Munich (Deutsches Herzzentrum München): Specialty cardiac hospital affiliated with the Technical University of Munich, providing interventional cardiology, cardiac surgery, and heart failure care. Strong parallels in dedicated cardiac specialty focus, research depth, and academic integration.
• Istituto Clinico Humanitas: Italian private specialty hospital with strong cardiology and cardiac surgery programs plus active research (affiliated with Humanitas University). Comparable in offering integrated specialty cardiac care, research, and training in the Italian-speaking region.
• HUG - Hôpitaux Universitaires de Genève: Swiss university hospital with a comprehensive cardiology service covering interventional, EP, and heart failure programs. Comparable Swiss public-sector specialty cardiac provider with academic and research orientation.
• St. Antonius Hospital (Nieuwegein, Netherlands): European specialty cardiac hospital known for interventional cardiology, cardiac surgery, and heart rhythm management. Direct European peer with similar depth in cardiovascular subspecialties and a strong procedural case mix.

Emerging players

• Texas Heart Institute: Research-intensive cardiac specialty institution focused on cardiovascular disease, including pioneering work in cell therapy and device innovation. Comparable in research-led orientation and emphasis on advanced cardiac therapies, though primarily U.S.-based and not a direct operating competitor.

Broad incumbents

• Cleveland Clinic Heart, Vascular & Thoracic Institute: Among the largest and most internationally recognized cardiac specialty programs globally, spanning interventional, surgical, and EP services. Provides a broader-incumbent benchmark for specialty cardiac care delivery, research output, and clinical reputation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC85cNvHyaerRnBTUMVC-TOw
• Facebookfacebook.com/Cardiocentro-Ticino-400934150076532
• LinkedInlinkedin.com/company/cardiocentro-ticino

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiocentro Ticino Institute